Hans Moebius
2023
In 2023, Hans Moebius earned a total compensation of $1.3M as Former Chief Medical Officer at Athira Pharma, a 39% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $172,050 |
|---|---|
| Option Awards | $531,999 |
| Salary | $465,000 |
| Other | $123,424 |
| Total | $1,292,474 |
Moebius received $532K in option awards, accounting for 41% of the total pay in 2023.
Moebius also received $172.1K in non-equity incentive plan, $465K in salary and $123.4K in other compensation.
Rankings
In 2023, Hans Moebius' compensation ranked 926th out of 2,910 executives tracked by ExecPay. In other words, Moebius earned more than 68.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 926 out of 2,910 | 68th |
Division Manufacturing | 551 out of 1,602 | 66th |
Major group Chemicals And Allied Products | 375 out of 901 | 58th |
Industry group Drugs | 364 out of 864 | 58th |
Industry Biological Products, Except Diagnostic Substances | 112 out of 211 | 47th |
Source: SEC filing on April 9, 2024.
Moebius' colleagues
We found two more compensation records of executives who worked with Hans Moebius at Athira Pharma in 2023.